Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

CEL SCI CORP (CVM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/20/2023 8-K Quarterly results
07/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/18/2023 8-K Quarterly results
07/17/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
07/17/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/14/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CEL-SCI CONCLUDES POSITIVE MEETING WITH U.S. FDA CONCERNING MULTIKINE’S APPROVAL FOR HEAD & NECK CANCER"
07/12/2023 8-K Quarterly results
05/23/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/02/2023 8-K Quarterly results
05/01/2023 8-K Quarterly results
04/19/2023 8-K Quarterly results
03/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CEL-SCI’s Multikine Phase 3 Cancer Study Shows 43% Survival Extension"
02/08/2023 SC 13G/A STATE STREET CORP reports a 0.5% stake in EXIT FILING CEL-SCI CORP
12/27/2022 10-K Annual Report for the period ended September 30, 2022
09/13/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CEL-SCI’S PHASE 3 DATA PRESENTED AT ESMO 2022: NEOADJUVANT MULTIKINE ACHIEVED GROUNDBREAKING TUMOR RESPONSE & EXTENDED OVERALL SURVIVAL IN LOCALLY ADVANCED HEAD AND NECK CANCER"
08/22/2022 8-K Quarterly results
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
07/18/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/18/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/01/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
07/01/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/01/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/13/2022 8-K Quarterly results
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/29/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/29/2022 ARS Form ARS - Annual Report to Security Holders:
04/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/11/2022 SC 13G/A STATE STREET CORP reports a 2.3% stake in EXIT FILING CEL-SCI CORP
02/11/2022 10-Q Quarterly Report for the period ended December 31, 2021
02/11/2022 SC 13G/A STATE STREET CORP reports a 7.8% stake in AMENDED FILING CEL-SCI CORP
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy